NCT06306573View on ClinicalTrials.gov

CardioMEMS HF System Real-World Evidence Post-Approval Study

Enrolling by invitationOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Heart Failure NYHA Class IIHeart Failure NYHA Class III
Interventions
DEVICE

CardioMEMS HF System

The CardioMEMS HF System provides pulmonary artery (PA) hemodynamic data to monitor and manage HF subjects. The CardioMEMS HF System measures PA pressure which clinicians use to initiate or modify HF treatment.

Trial Locations (1)

30313

Abbott Medical, Atlanta

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY